INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,398 | – | 279 | – | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 21 | +133.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -73.5% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 34 | -8.1% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 37 | -46.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | 0.0% | 69 | +27.8% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +28.6% | 54 | -40.7% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +250.0% | 91 | +102.2% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | +73.1% | 0.00% | – |
| Q3 2020 | $1,000 | – | 26 | +44.4% | 0.00% | – |
| Q2 2020 | $0 | – | 18 | -14.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 21 | -63.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |